COVID-19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies.

Saved in:
Bibliographic Details
Title: COVID-19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies.
Authors: Foxworthy B; Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA., Dai C; Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA., Davis EC; Department of Surgery, Boston University, Boston, USA., Xavier AC; Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA., Brackett J; Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Dickens D; Pediatric Hematology-Oncology, Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA., Kahn A; Pediatric Hematology-Oncology, Department of Pediatrics, Saint Joseph's University Medical Center, Paterson, New Jersey, USA., Martinez I; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama, USA., Sharma A; Pediatric Hematology-Oncology, Department of Pediatrics, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Schwalm C; Pediatric Hematology-Oncology, Bronson Methodist Hospital, Kalamazoo, Michigan, USA., Foley J; Pediatric Hematology-Oncology, Helen DeVos Children's Hospital, Grand Rapids, Michigan, USA., Wilkes J; Department of Pediatrics, Division of Cancer and Blood Disorders, University of Washington, Seattle, Washington, USA., Bhatia S; Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama, USA., Levine JM; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, District of Columbia, USA., Johnston EE; Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama, USA., Wolfson JA; Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Corporate Authors: POCC Consortium
Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Aug; Vol. 71 (8), pp. e31082. Date of Electronic Publication: 2024 May 28.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38804869
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: COVID-19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Foxworthy+B%22">Foxworthy B</searchLink>; Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Dai+C%22">Dai C</searchLink>; Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Davis+EC%22">Davis EC</searchLink>; Department of Surgery, Boston University, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Xavier+AC%22">Xavier AC</searchLink>; Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Brackett+J%22">Brackett J</searchLink>; Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Dickens+D%22">Dickens D</searchLink>; Pediatric Hematology-Oncology, Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA.<br /><searchLink fieldCode="AU" term="%22Kahn+A%22">Kahn A</searchLink>; Pediatric Hematology-Oncology, Department of Pediatrics, Saint Joseph's University Medical Center, Paterson, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Martinez+I%22">Martinez I</searchLink>; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Sharma+A%22">Sharma A</searchLink>; Pediatric Hematology-Oncology, Department of Pediatrics, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Schwalm+C%22">Schwalm C</searchLink>; Pediatric Hematology-Oncology, Bronson Methodist Hospital, Kalamazoo, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Foley+J%22">Foley J</searchLink>; Pediatric Hematology-Oncology, Helen DeVos Children's Hospital, Grand Rapids, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Wilkes+J%22">Wilkes J</searchLink>; Department of Pediatrics, Division of Cancer and Blood Disorders, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Bhatia+S%22">Bhatia S</searchLink>; Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Levine+JM%22">Levine JM</searchLink>; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Johnston+EE%22">Johnston EE</searchLink>; Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Wolfson+JA%22">Wolfson JA</searchLink>; Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22POCC+Consortium%22">POCC Consortium</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101186624%22">Pediatric blood & cancer</searchLink> [Pediatr Blood Cancer] 2024 Aug; Vol. 71 (8), pp. e31082. <i>Date of Electronic Publication: </i>2024 May 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley%22">John Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101186624 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1545-5017 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215455009%22">15455009 </searchLink><i>NLM ISO Abbreviation: </i>Pediatr Blood Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38804869
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/pbc.31082
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e31082
    Titles:
      – TitleFull: COVID-19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Foxworthy B
      – PersonEntity:
          Name:
            NameFull: Dai C
      – PersonEntity:
          Name:
            NameFull: Davis EC
      – PersonEntity:
          Name:
            NameFull: Xavier AC
      – PersonEntity:
          Name:
            NameFull: Brackett J
      – PersonEntity:
          Name:
            NameFull: Dickens D
      – PersonEntity:
          Name:
            NameFull: Kahn A
      – PersonEntity:
          Name:
            NameFull: Martinez I
      – PersonEntity:
          Name:
            NameFull: Sharma A
      – PersonEntity:
          Name:
            NameFull: Schwalm C
      – PersonEntity:
          Name:
            NameFull: Foley J
      – PersonEntity:
          Name:
            NameFull: Wilkes J
      – PersonEntity:
          Name:
            NameFull: Bhatia S
      – PersonEntity:
          Name:
            NameFull: Levine JM
      – PersonEntity:
          Name:
            NameFull: Johnston EE
      – PersonEntity:
          Name:
            NameFull: Wolfson JA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2024 Aug
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1545-5017
          Numbering:
            – Type: volume
              Value: 71
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Pediatric blood & cancer
              Type: main
ResultId 1